GLP-1 prescription telehealth across Europe

GLP-1 receptor agonists are now accessible through regulated telehealth platforms across the EU. If you're considering this treatment for weight management or metabolic health, you no longer need to wait for in-person appointments or travel to specialist clinics.

Who this is for

GLP-1 prescription telehealth suits people who:

• Have a BMI over 27 with weight-related health concerns, or BMI over 30
• Are motivated to lose weight but struggle with appetite control or blood sugar stability
• Live far from endocrinologists or weight management specialists
• Prefer privacy and convenience of home-based consultations
• Want ongoing medical oversight without frequent clinic visits

You may be a good candidate if you've tried lifestyle changes alone and found them insufficient, or if you have type 2 diabetes and want to explore GLP-1 as part of your management plan. A physician assessment will confirm whether this treatment aligns with your health profile and goals.

How GLP-1 telehealth works

The process mirrors traditional prescribing but removes geographical barriers. Here's the mechanism:

Assessment: You complete a detailed health questionnaire covering weight history, metabolic markers, medications, and any contraindications. This takes 10-15 minutes and captures the clinical picture a doctor needs.

Physician review: A licensed physician in your jurisdiction reviews your assessment, checks for drug interactions, and evaluates whether GLP-1 is appropriate. This typically happens within 24-48 hours.

Prescription and supply: If approved, your prescription is issued and sent to a regulated pharmacy. You receive your medication (usually a weekly injection pen) at home, with full instructions.

Ongoing support: You'll have scheduled follow-ups at weeks 2, 4, and 12 to monitor tolerance, side effects, and weight progress. Your doctor adjusts dosing if needed and can pause or stop treatment if complications arise.

The clinical logic is straightforward: GLP-1 agonists work by slowing gastric emptying and signalling satiety to the brain, reducing appetite and calorie intake. Regular medical oversight ensures you're tolerating the medication and achieving your goals safely.

What to expect: timeline and costs

Most people move from first assessment to first injection within 3-5 working days.

Costs vary by provider and location, but typically:

• Initial consultation and assessment: EUR 30-60
• Monthly medication cost: EUR 150-300 (depending on dose and brand)
• Follow-up consultations: EUR 20-40 each

Some EU health systems cover GLP-1 for type 2 diabetes; coverage for weight management alone is less common. Check your national health insurance or ask your provider about reimbursement eligibility.

Side effects are common in the first 2-4 weeks (nausea, mild vomiting, constipation) but usually settle as your body adapts. Your doctor will discuss management strategies and may suggest dose adjustments.

You'll need to commit to weekly injections and regular check-ins. Treatment typically continues for 6-12 months, though some people maintain longer-term use. Stopping the medication usually results in gradual weight regain, so lifestyle changes during treatment are essential.

GLP-1 telehealth in the EU regulatory context

EU telehealth is regulated at the member state level, but all licensed platforms must comply with the Directive on the Establishment of a European Health Data Space and national medical practice laws.

In Portugal, where AETHERA Health operates, telehealth prescriptions are issued by physicians registered with the Ordem dos Médicos and dispensed by licensed pharmacies. Your data is held under GDPR and Portuguese data protection law. Prescriptions are valid across the EU under the cross-border healthcare framework, though some countries may require local registration.

Other EU countries (Spain, Germany, France, Netherlands) have similar frameworks: licensed doctors, regulated pharmacies, and data protection standards. Telehealth GLP-1 prescriptions are legal and increasingly common, though availability and cost vary by country.

If you're travelling or relocating within the EU, your prescription can often be transferred or renewed by a local provider. Always confirm with your telehealth platform that they serve your current location.

Next step

If you're ready to explore whether GLP-1 is right for you, the first step is a confidential health assessment. A physician will review your medical history, current weight and metabolic health, and any previous treatments. This takes 15 minutes and carries no obligation.

Take the assessment at https://aetherahealth.eu/assessment/weight